| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | peptidyltransferase activity | 5.19e-06 | 6 | 129 | 3 | GO:0000048 | |
| GeneOntologyMolecularFunction | leukotriene-C(4) hydrolase | 5.19e-06 | 6 | 129 | 3 | GO:0002951 | |
| GeneOntologyMolecularFunction | threonine-type peptidase activity | 7.43e-06 | 20 | 129 | 4 | GO:0070003 | |
| GeneOntologyMolecularFunction | leukotriene C4 gamma-glutamyl transferase activity | 1.44e-05 | 8 | 129 | 3 | GO:0103068 | |
| GeneOntologyMolecularFunction | glutathione hydrolase activity | 2.15e-05 | 9 | 129 | 3 | GO:0036374 | |
| GeneOntologyMolecularFunction | kinase activity | ERBB2 PDK1 INSR SIK1 ADCK2 LRRK1 TRRAP NRP1 JAK1 COQ8A CSK PAK2 PRKCD AK2 PRKDC PAN3 | 3.41e-05 | 764 | 129 | 16 | GO:0016301 |
| GeneOntologyMolecularFunction | protein kinase activity | ERBB2 PDK1 INSR SIK1 ADCK2 LRRK1 NRP1 JAK1 COQ8A CSK PAK2 PRKCD PRKDC PAN3 | 3.43e-05 | 600 | 129 | 14 | GO:0004672 |
| GeneOntologyMolecularFunction | steroid 11-beta-monooxygenase activity | 4.14e-05 | 2 | 129 | 2 | GO:0004507 | |
| GeneOntologyMolecularFunction | corticosterone 18-monooxygenase activity | 4.14e-05 | 2 | 129 | 2 | GO:0047783 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 8.48e-05 | 279 | 129 | 9 | GO:0005096 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | DOCK3 DOCK4 RANBP1 DENND1C ARHGEF17 PREX2 NRP1 ARFGEF3 RGS14 NPRL3 RACGAP1 RAPGEF2 | 1.12e-04 | 507 | 129 | 12 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | DOCK3 DOCK4 RANBP1 DENND1C ARHGEF17 PREX2 NRP1 ARFGEF3 RGS14 NPRL3 RACGAP1 RAPGEF2 | 1.12e-04 | 507 | 129 | 12 | GO:0030695 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | ERBB2 PDK1 POLE INSR SIK1 ADCK2 LRRK1 TRRAP NRP1 JAK1 COQ8A CSK PAK2 PRKCD AK2 PRKDC PAN3 | 1.14e-04 | 938 | 129 | 17 | GO:0016772 |
| GeneOntologyMolecularFunction | omega peptidase activity | 1.39e-04 | 16 | 129 | 3 | GO:0008242 | |
| GeneOntologyMolecularFunction | protein kinase binding | DOCK4 ERBB2 HIF1A INSR SIK1 CLASP2 NRP1 RGS14 JUP CSK PAK2 RACGAP1 PRKCD AKAP11 RAPGEF2 CDC25B | 1.62e-04 | 873 | 129 | 16 | GO:0019901 |
| GeneOntologyMolecularFunction | ATP-dependent activity | RAD51C ABCC3 DNAH3 ABCA2 MYO6 ATAD5 SMC6 PSMC4 CHD9 YTHDC2 DNAH1 ABCD4 ABCC2 | 1.74e-04 | 614 | 129 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | ERBB2 PDK1 INSR SIK1 ADCK2 LRRK1 NRP1 JAK1 COQ8A CSK PAK2 PRKCD PRKDC PAN3 | 2.01e-04 | 709 | 129 | 14 | GO:0016773 |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 2.81e-04 | 49 | 129 | 4 | GO:0140359 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 3.61e-04 | 145 | 129 | 6 | GO:0004713 | |
| GeneOntologyMolecularFunction | kinase binding | DOCK4 ERBB2 HIF1A INSR SIK1 CLASP2 NRP1 RGS14 JUP CSK PAK2 RACGAP1 PRKCD AKAP11 RAPGEF2 CDC25B | 5.18e-04 | 969 | 129 | 16 | GO:0019900 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 5.92e-04 | 441 | 129 | 10 | GO:0016887 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 7.66e-04 | 231 | 129 | 7 | GO:0005085 | |
| GeneOntologyMolecularFunction | ABC-type glutathione S-conjugate transporter activity | 1.13e-03 | 8 | 129 | 2 | GO:0015431 | |
| GeneOntologyMolecularFunction | phosphatase binding | 1.66e-03 | 264 | 129 | 7 | GO:0019902 | |
| GeneOntologyMolecularFunction | ATPase-coupled inorganic anion transmembrane transporter activity | 1.80e-03 | 10 | 129 | 2 | GO:0043225 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | DOCK3 DOCK4 RANBP1 ABCA2 DENND1C ARHGEF17 PREX2 NRP1 ARFGEF3 RGS14 PPP2R2A NPRL3 PAK2 RACGAP1 PRKCD AKAP11 RAPGEF2 PPP1R36 SERPINA5 | 1.90e-03 | 1418 | 129 | 19 | GO:0030234 |
| GeneOntologyMolecularFunction | protein phosphatase binding | 2.45e-03 | 210 | 129 | 6 | GO:0019903 | |
| GeneOntologyBiologicalProcess | cell cycle process | RAD51C RANBP1 MYBBP1A CLASP1 ATAD5 POLE ANXA11 SUN1 INSR SMC6 YTHDC2 CLASP2 TRRAP FANCA CDCA2 RGS14 TRAPPC12 ANAPC1 ZC3H12D RACGAP1 ING4 PRKDC CDC25B TOP3B | 9.01e-06 | 1441 | 129 | 24 | GO:0022402 |
| GeneOntologyBiologicalProcess | cysteine biosynthetic process | 1.31e-05 | 8 | 129 | 3 | GO:0019344 | |
| GeneOntologyBiologicalProcess | leukotriene D4 biosynthetic process | 2.78e-05 | 10 | 129 | 3 | GO:1901750 | |
| GeneOntologyBiologicalProcess | peptide modification | 2.78e-05 | 10 | 129 | 3 | GO:0031179 | |
| GeneOntologyBiologicalProcess | ketone biosynthetic process | 2.86e-05 | 57 | 129 | 5 | GO:0042181 | |
| GeneOntologyBiologicalProcess | glutathione catabolic process | 3.80e-05 | 11 | 129 | 3 | GO:0006751 | |
| GeneOntologyBiologicalProcess | leukotriene D4 metabolic process | 5.05e-05 | 12 | 129 | 3 | GO:1901748 | |
| GeneOntologyBiologicalProcess | regulation of phosphate metabolic process | ERBB2 HIF1A ABCA2 IL18 SEMA7A PDK1 INSR LRRK1 ME1 DIPK2A NRP1 CDCA2 RGS14 TLR3 PAK2 PRKCD AKAP11 PRKDC RAPGEF2 CDC25B PPP1R36 INPP5J | 6.77e-05 | 1421 | 129 | 22 | GO:0019220 |
| GeneOntologyBiologicalProcess | regulation of phosphorus metabolic process | ERBB2 HIF1A ABCA2 IL18 SEMA7A PDK1 INSR LRRK1 ME1 DIPK2A NRP1 CDCA2 RGS14 TLR3 PAK2 PRKCD AKAP11 PRKDC RAPGEF2 CDC25B PPP1R36 INPP5J | 6.91e-05 | 1423 | 129 | 22 | GO:0051174 |
| GeneOntologyBiologicalProcess | cysteine metabolic process | 1.26e-04 | 16 | 129 | 3 | GO:0006534 | |
| GeneOntologyBiologicalProcess | ubiquinone biosynthetic process | 1.52e-04 | 17 | 129 | 3 | GO:0006744 | |
| GeneOntologyBiologicalProcess | quinone biosynthetic process | 1.52e-04 | 17 | 129 | 3 | GO:1901663 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle | RAD51C RANBP1 CLASP1 ATAD5 POLE INSR SIK1 YTHDC2 CLASP2 TRRAP CDCA2 RGS14 ANAPC1 ZC3H12D RACGAP1 PRKDC CDC25B | 1.97e-04 | 1014 | 129 | 17 | GO:0000278 |
| MousePheno | ovary hypoplasia | 7.35e-07 | 10 | 110 | 4 | MP:0005158 | |
| MousePheno | abnormal circulating glutathione level | 4.69e-06 | 5 | 110 | 3 | MP:0030652 | |
| MousePheno | increased circulating glutathione level | 4.69e-06 | 5 | 110 | 3 | MP:0030653 | |
| MousePheno | glutathionuria | 4.69e-06 | 5 | 110 | 3 | MP:0013730 | |
| MousePheno | increased glutathione level | 4.69e-06 | 5 | 110 | 3 | MP:0012606 | |
| MousePheno | decreased spleen red pulp amount | 6.14e-06 | 16 | 110 | 4 | MP:0008477 | |
| MousePheno | absent corpus luteum | 1.28e-05 | 66 | 110 | 6 | MP:0001134 | |
| MousePheno | decreased circulating cysteine level | 1.62e-05 | 7 | 110 | 3 | MP:0030626 | |
| MousePheno | decreased cysteine level | 2.58e-05 | 8 | 110 | 3 | MP:0030623 | |
| MousePheno | epididymis hypoplasia | 2.58e-05 | 8 | 110 | 3 | MP:0004932 | |
| MousePheno | abnormal corpus luteum morphology | 3.55e-05 | 116 | 110 | 7 | MP:0002679 | |
| MousePheno | nervous | 3.85e-05 | 9 | 110 | 3 | MP:0008912 | |
| MousePheno | decreased circulating renin level | 5.47e-05 | 10 | 110 | 3 | MP:0003353 | |
| MousePheno | failure of copulatory plug deposition | 5.47e-05 | 10 | 110 | 3 | MP:0030983 | |
| MousePheno | seminal vesicle hypoplasia | 5.47e-05 | 10 | 110 | 3 | MP:0005148 | |
| MousePheno | abnormal urine progesterone level | 6.14e-05 | 2 | 110 | 2 | MP:0011545 | |
| MousePheno | abnormal urine deoxycorticosterone level | 6.14e-05 | 2 | 110 | 2 | MP:0011552 | |
| MousePheno | decreased urine corticosterone level | 6.14e-05 | 2 | 110 | 2 | MP:0011550 | |
| MousePheno | increased urine deoxycorticosterone level | 6.14e-05 | 2 | 110 | 2 | MP:0011553 | |
| MousePheno | increased urine progesterone level | 6.14e-05 | 2 | 110 | 2 | MP:0011546 | |
| MousePheno | aciduria | 7.00e-05 | 55 | 110 | 5 | MP:0010028 | |
| MousePheno | abnormal circulating cysteine level | 7.47e-05 | 11 | 110 | 3 | MP:0030624 | |
| MousePheno | absent tertiary ovarian follicles | 7.47e-05 | 11 | 110 | 3 | MP:0011130 | |
| MousePheno | increased circulating protein level | USP53 MYBBP1A IL18 ROGDI MYO6 CIB3 CYP11B1 CYP11B2 INSR SMC6 PSMB10 LAMA4 CHD9 SIK1 LRRK1 ME1 CHST8 JAK1 ANAPC1 BBS7 TLR3 ZC3H12D PAK2 ING4 ABCC2 | 1.01e-04 | 1433 | 110 | 25 | MP:0014501 |
| MousePheno | increased circulating mineral level | MYBBP1A ABCA2 HECW1 MYO6 CYP11B1 CYP11B2 SUN1 SMC6 ADCK2 LRRK1 BTBD2 JAK1 BBS7 ING4 PRKDC | 1.12e-04 | 626 | 110 | 15 | MP:0014547 |
| MousePheno | abnormal cysteine level | 1.28e-04 | 13 | 110 | 3 | MP:0030621 | |
| MousePheno | decreased glutathione level | 1.28e-04 | 13 | 110 | 3 | MP:0012604 | |
| MousePheno | abnormal glutathione level | 1.28e-04 | 13 | 110 | 3 | MP:0012603 | |
| MousePheno | priapism | 1.62e-04 | 14 | 110 | 3 | MP:0003415 | |
| MousePheno | increased urine osmolality | 1.62e-04 | 14 | 110 | 3 | MP:0008055 | |
| MousePheno | abnormal female germ cell morphology | 1.80e-04 | 150 | 110 | 7 | MP:0006361 | |
| MousePheno | abnormal spinal nerve morphology | 1.96e-04 | 107 | 110 | 6 | MP:0001077 | |
| MousePheno | increased mineral level | MYBBP1A ABCA2 HECW1 MYO6 CYP11B1 CYP11B2 SUN1 SMC6 ADCK2 LRRK1 BTBD2 JAK1 BBS7 ING4 PRKDC | 2.28e-04 | 668 | 110 | 15 | MP:0014535 |
| MousePheno | increased circulating pituitary hormone level | 2.28e-04 | 110 | 110 | 6 | MP:0005117 | |
| MousePheno | abnormal copulatory plug deposition | 2.46e-04 | 16 | 110 | 3 | MP:0030982 | |
| MousePheno | abnormal enzyme/coenzyme level | USP53 MYBBP1A ROGDI MYO6 CIB3 CYP11B1 CYP11B2 LAMA4 CHD9 SIK1 ADCK2 LRRK1 ME1 ADCY3 CHST8 JAK1 CLPTM1L COQ8A ANAPC1 BBS7 ZC3H12D PAK2 ING4 ABCC2 | 3.21e-04 | 1451 | 110 | 24 | MP:0005319 |
| MousePheno | failure of superovulation | 3.55e-04 | 18 | 110 | 3 | MP:0031422 | |
| MousePheno | abnormal penile erection | 3.55e-04 | 18 | 110 | 3 | MP:0001379 | |
| MousePheno | oocyte degeneration | 3.55e-04 | 18 | 110 | 3 | MP:0009093 | |
| MousePheno | abnormal uterus size | 3.60e-04 | 168 | 110 | 7 | MP:0004902 | |
| MousePheno | abnormal adrenal gland zona glomerulosa morphology | 3.64e-04 | 4 | 110 | 2 | MP:0008293 | |
| MousePheno | decreased urine aldosterone level | 3.64e-04 | 4 | 110 | 2 | MP:0011541 | |
| MousePheno | abnormal urine aldosterone level | 3.64e-04 | 4 | 110 | 2 | MP:0011539 | |
| MousePheno | abnormal urine corticosterone level | 3.64e-04 | 4 | 110 | 2 | MP:0011548 | |
| MousePheno | decreased urine hormone level | 3.64e-04 | 4 | 110 | 2 | MP:0014459 | |
| MousePheno | increased circulating growth hormone level | 4.19e-04 | 19 | 110 | 3 | MP:0005123 | |
| MousePheno | abnormal adrenal gland zona fasciculata morphology | 4.19e-04 | 19 | 110 | 3 | MP:0008294 | |
| MousePheno | poor circulation | 4.19e-04 | 19 | 110 | 3 | MP:0001633 | |
| MousePheno | abnormal ventral spinal root morphology | 4.19e-04 | 19 | 110 | 3 | MP:0003993 | |
| MousePheno | abnormal copulation physiology | 4.19e-04 | 19 | 110 | 3 | MP:0031627 | |
| MousePheno | abnormal circulating alkaline phosphatase level | USP53 MYBBP1A ROGDI MYO6 LAMA4 CHD9 SIK1 LRRK1 ME1 JAK1 CLPTM1L ANAPC1 ING4 ABCC2 | 4.79e-04 | 639 | 110 | 14 | MP:0000202 |
| MousePheno | short femur | 4.95e-04 | 127 | 110 | 6 | MP:0003109 | |
| MousePheno | increased pituitary hormone level | 5.16e-04 | 128 | 110 | 6 | MP:0003973 | |
| MousePheno | decreased femur size | 5.60e-04 | 130 | 110 | 6 | MP:0030825 | |
| MousePheno | increased adrenal gland zona fasciculata size | 6.04e-04 | 5 | 110 | 2 | MP:0014286 | |
| MousePheno | abnormal circulating mineral level | MYBBP1A ABCA2 ROGDI HECW1 MYO6 CYP11B1 CYP11B2 SUN1 SMC6 ADCK2 LRRK1 BTBD2 TRRAP JAK1 JUP BBS7 ING4 PRKDC | 6.24e-04 | 982 | 110 | 18 | MP:0006357 |
| MousePheno | small vertebrae | 6.55e-04 | 22 | 110 | 3 | MP:0004610 | |
| MousePheno | increased growth hormone level | 7.49e-04 | 23 | 110 | 3 | MP:0005137 | |
| MousePheno | uterus hypoplasia | 7.49e-04 | 23 | 110 | 3 | MP:0001121 | |
| MousePheno | abnormal ovary morphology | RAD51C ATAD5 CYP11B1 CYP11B2 SUN1 YTHDC2 GGT2P GGT1 GGT3P CHST8 FANCA | 8.41e-04 | 451 | 110 | 11 | MP:0001126 |
| MousePheno | abnormal copulation behavior | 8.51e-04 | 24 | 110 | 3 | MP:0009697 | |
| MousePheno | uterus adenomyosis | 9.02e-04 | 6 | 110 | 2 | MP:0009221 | |
| MousePheno | increased urine hormone level | 9.02e-04 | 6 | 110 | 2 | MP:0014458 | |
| MousePheno | adrenal gland hyperplasia | 9.02e-04 | 6 | 110 | 2 | MP:0009078 | |
| MousePheno | abnormal circulating enzyme level | USP53 MYBBP1A ROGDI MYO6 CIB3 CYP11B1 CYP11B2 LAMA4 CHD9 SIK1 LRRK1 ME1 ADCY3 CHST8 JAK1 CLPTM1L ANAPC1 BBS7 ZC3H12D PAK2 ING4 ABCC2 | 9.07e-04 | 1372 | 110 | 22 | MP:0001570 |
| MousePheno | abnormal circulating phosphate level | 1.03e-03 | 260 | 110 | 8 | MP:0001565 | |
| MousePheno | abnormal phosphate level | 1.08e-03 | 262 | 110 | 8 | MP:0020885 | |
| MousePheno | nuclear cataract | 1.08e-03 | 26 | 110 | 3 | MP:0010254 | |
| MousePheno | abnormal renal/urinary system physiology | CYP11B1 CYP11B2 INSR ADCK2 ADCY3 GGT2P GGT1 GGT3P JAK1 PRKCD AKAP11 PRKDC ABCC2 TOP3B | 1.09e-03 | 695 | 110 | 14 | MP:0005502 |
| MousePheno | abnormal urine homeostasis | CYP11B1 CYP11B2 INSR ADCK2 GGT2P GGT1 GGT3P JAK1 AKAP11 PRKDC ABCC2 | 1.10e-03 | 466 | 110 | 11 | MP:0009643 |
| MousePheno | abnormal brain weight | 1.10e-03 | 148 | 110 | 6 | MP:0012775 | |
| MousePheno | decreased circulating enzyme level | 1.11e-03 | 263 | 110 | 8 | MP:0014451 | |
| MousePheno | abnormal urine hormone level | 1.26e-03 | 7 | 110 | 2 | MP:0011538 | |
| MousePheno | pituitary gland hyperplasia | 1.26e-03 | 7 | 110 | 2 | MP:0000635 | |
| MousePheno | abnormal motor learning | 1.26e-03 | 60 | 110 | 4 | MP:0002804 | |
| MousePheno | abnormal epididymis morphology | 1.28e-03 | 269 | 110 | 8 | MP:0002631 | |
| MousePheno | abnormal female reproductive gland morphology | RAD51C ATAD5 CYP11B1 CYP11B2 SUN1 YTHDC2 GGT2P GGT1 GGT3P CHST8 FANCA | 1.28e-03 | 475 | 110 | 11 | MP:0013324 |
| MousePheno | abnormal motor coordination/balance | DOCK3 ABCA2 HECW1 NRDC MYO6 CIB3 FOLH1 TNC SUN1 SMC6 LAMA4 ADCK2 PREX2 JUP COQ8A TLR3 | 1.29e-03 | 873 | 110 | 16 | MP:0001516 |
| MousePheno | abnormal female reproductive system physiology | RAD51C ABCA2 CYP11B1 CYP11B2 SUN1 PSMC4 YTHDC2 ADCY3 GGT2P GGT1 GGT3P CHST8 FANCA TLR3 CDC25B TOP3B | 1.33e-03 | 876 | 110 | 16 | MP:0003699 |
| MousePheno | increased circulating enzyme level | USP53 MYBBP1A ROGDI MYO6 CIB3 CYP11B1 CYP11B2 LAMA4 CHD9 SIK1 LRRK1 ME1 CHST8 JAK1 ANAPC1 BBS7 ZC3H12D PAK2 ABCC2 | 1.36e-03 | 1140 | 110 | 19 | MP:0014450 |
| MousePheno | short tibia | 1.44e-03 | 274 | 110 | 8 | MP:0002764 | |
| MousePheno | increased enzyme/coenzyme level | USP53 MYBBP1A ROGDI MYO6 CIB3 CYP11B1 CYP11B2 LAMA4 CHD9 SIK1 LRRK1 ME1 CHST8 JAK1 ANAPC1 BBS7 ZC3H12D PAK2 ABCC2 | 1.48e-03 | 1148 | 110 | 19 | MP:0014448 |
| MousePheno | abnormal learning/memory/conditioning | DOCK3 ABCA2 ROGDI HECW1 NRDC CIB3 FOLH1 TNC ADCK2 GRM4 ADCY3 RGS14 CLPTM1L COQ8A CSK BAZ1A TLR3 ABCD4 RAPGEF2 KCNT1 | 1.48e-03 | 1239 | 110 | 20 | MP:0002063 |
| MousePheno | abnormal circulating renin level | 1.49e-03 | 29 | 110 | 3 | MP:0003349 | |
| MousePheno | abnormal second pharyngeal arch morphology | 1.49e-03 | 29 | 110 | 3 | MP:0006338 | |
| MousePheno | aminoaciduria | 1.49e-03 | 29 | 110 | 3 | MP:0003311 | |
| MousePheno | abnormal pituitary hormone level | 1.50e-03 | 214 | 110 | 7 | MP:0003965 | |
| MousePheno | small seminiferous tubules | 1.55e-03 | 107 | 110 | 5 | MP:0001153 | |
| MousePheno | abnormal cognition | DOCK3 ABCA2 ROGDI HECW1 NRDC CIB3 FOLH1 TNC ADCK2 GRM4 ADCY3 RGS14 CLPTM1L COQ8A CSK BAZ1A TLR3 ABCD4 RAPGEF2 KCNT1 | 1.59e-03 | 1246 | 110 | 20 | MP:0014114 |
| MousePheno | abnormal mineral level | MYBBP1A ABCA2 ROGDI HECW1 MYO6 CYP11B1 CYP11B2 SUN1 SMC6 ADCK2 LRRK1 BTBD2 TRRAP JAK1 JUP BBS7 ING4 PRKDC | 1.60e-03 | 1066 | 110 | 18 | MP:0000192 |
| MousePheno | increased circulating angiotensin II level | 1.67e-03 | 8 | 110 | 2 | MP:0031232 | |
| MousePheno | increased angiotensin II level | 1.67e-03 | 8 | 110 | 2 | MP:0031229 | |
| MousePheno | fused outer hair cell stereocilia | 1.67e-03 | 8 | 110 | 2 | MP:0004528 | |
| MousePheno | increased macrophage cell number | 1.75e-03 | 162 | 110 | 6 | MP:0005425 | |
| MousePheno | abnormal mineral homeostasis | MYBBP1A ABCA2 ROGDI HECW1 MYO6 CYP11B1 CYP11B2 SUN1 SMC6 ADCK2 LRRK1 BTBD2 TRRAP JAK1 JUP BBS7 ING4 PRKDC | 1.77e-03 | 1076 | 110 | 18 | MP:0005636 |
| MousePheno | decreased enzyme/conezyme level | 1.80e-03 | 284 | 110 | 8 | MP:0014449 | |
| MousePheno | abnormal seminiferous tubule size | 1.82e-03 | 111 | 110 | 5 | MP:0006307 | |
| Domain | ARM-type_fold | DOCK3 ZYG11A MYBBP1A CLASP1 NOC2L IFT172 CLASP2 TRRAP ARFGEF3 JUP CEBPZ PRKDC | 2.96e-06 | 339 | 125 | 12 | IPR016024 |
| Domain | AAA | 5.65e-06 | 144 | 125 | 8 | SM00382 | |
| Domain | AAA+_ATPase | 5.65e-06 | 144 | 125 | 8 | IPR003593 | |
| Domain | Kinase-like_dom | ERBB2 INSR CHD9 SIK1 ADCK2 LRRK1 TRRAP JAK1 COQ8A CSK PAK2 PRKCD PRKDC PAN3 | 1.62e-05 | 542 | 125 | 14 | IPR011009 |
| Domain | - | RAD51C MPP2 ABCC3 DNAH3 ABCA2 ATAD5 SPEF2 SMC6 PSMC4 CHD9 YTHDC2 LRRK1 DNAH1 ABCD4 AK2 ABCC2 | 3.84e-05 | 746 | 125 | 16 | 3.40.50.300 |
| Domain | Cyt_P450_mitochondrial | 4.44e-05 | 2 | 125 | 2 | IPR002399 | |
| Domain | P-loop_NTPase | RAD51C MPP2 ABCC3 DNAH3 ABCA2 MYO6 ATAD5 SPEF2 SMC6 PSMC4 CHD9 YTHDC2 LRRK1 DNAH1 ABCD4 AK2 ABCC2 | 5.03e-05 | 848 | 125 | 17 | IPR027417 |
| Domain | ABC_transporter_CS | 1.76e-04 | 42 | 125 | 4 | IPR017871 | |
| Domain | CLASP_N | 2.64e-04 | 4 | 125 | 2 | PF12348 | |
| Domain | CLASP_N_dom | 2.64e-04 | 4 | 125 | 2 | IPR024395 | |
| Domain | Multidrug-R_assoc | 2.64e-04 | 4 | 125 | 2 | IPR005292 | |
| Domain | ABC_tran | 2.96e-04 | 48 | 125 | 4 | PF00005 | |
| Domain | HEAT | 2.96e-04 | 48 | 125 | 4 | PF02985 | |
| Domain | ABC_TRANSPORTER_2 | 2.96e-04 | 48 | 125 | 4 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 3.21e-04 | 49 | 125 | 4 | PS00211 | |
| Domain | ABC_transporter-like | 3.47e-04 | 50 | 125 | 4 | IPR003439 | |
| Domain | DOCK_N | 4.39e-04 | 5 | 125 | 2 | PF16172 | |
| Domain | DOCK_N | 4.39e-04 | 5 | 125 | 2 | IPR032376 | |
| Domain | PHR | 4.39e-04 | 5 | 125 | 2 | IPR012983 | |
| Domain | UbiB_dom | 4.39e-04 | 5 | 125 | 2 | IPR004147 | |
| Domain | PHR | 4.39e-04 | 5 | 125 | 2 | PF08005 | |
| Domain | ABC1 | 4.39e-04 | 5 | 125 | 2 | PF03109 | |
| Domain | PROTEIN_KINASE_DOM | 4.80e-04 | 493 | 125 | 11 | PS50011 | |
| Domain | HEAT | 6.14e-04 | 58 | 125 | 4 | IPR000357 | |
| Domain | FAT | 6.55e-04 | 6 | 125 | 2 | PS51189 | |
| Domain | FATC | 6.55e-04 | 6 | 125 | 2 | PS51190 | |
| Domain | FAT | 6.55e-04 | 6 | 125 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 6.55e-04 | 6 | 125 | 2 | IPR003151 | |
| Domain | FATC_dom | 6.55e-04 | 6 | 125 | 2 | IPR003152 | |
| Domain | PIK_FAT | 6.55e-04 | 6 | 125 | 2 | IPR014009 | |
| Domain | FATC | 6.55e-04 | 6 | 125 | 2 | SM01343 | |
| Domain | ABC_TM1F | 8.48e-04 | 28 | 125 | 3 | PS50929 | |
| Domain | ABC1_TM_dom | 8.48e-04 | 28 | 125 | 3 | IPR011527 | |
| Domain | GGT_peptidase | 9.13e-04 | 7 | 125 | 2 | IPR000101 | |
| Domain | G_glu_transpept | 9.13e-04 | 7 | 125 | 2 | PF01019 | |
| Domain | Recep_L_domain | 9.13e-04 | 7 | 125 | 2 | PF01030 | |
| Domain | Furin-like | 9.13e-04 | 7 | 125 | 2 | PF00757 | |
| Domain | Rcpt_L-dom | 9.13e-04 | 7 | 125 | 2 | IPR000494 | |
| Domain | G_GLU_TRANSPEPTIDASE | 9.13e-04 | 7 | 125 | 2 | PS00462 | |
| Domain | Furin-like_Cys-rich_dom | 9.13e-04 | 7 | 125 | 2 | IPR006211 | |
| Domain | - | 9.13e-04 | 7 | 125 | 2 | 3.80.20.20 | |
| Domain | Adenylat/UMP-CMP_kin | 1.93e-03 | 10 | 125 | 2 | IPR000850 | |
| Domain | DHR-1_domain | 2.35e-03 | 11 | 125 | 2 | IPR027007 | |
| Domain | DHR_2 | 2.35e-03 | 11 | 125 | 2 | PS51651 | |
| Domain | DHR_1 | 2.35e-03 | 11 | 125 | 2 | PS51650 | |
| Domain | DHR-2 | 2.35e-03 | 11 | 125 | 2 | PF06920 | |
| Domain | DOCK | 2.35e-03 | 11 | 125 | 2 | IPR026791 | |
| Domain | DOCK_C | 2.35e-03 | 11 | 125 | 2 | IPR010703 | |
| Domain | DOCK-C2 | 2.35e-03 | 11 | 125 | 2 | PF14429 | |
| Domain | DHR-2 | 2.35e-03 | 11 | 125 | 2 | IPR027357 | |
| Domain | Tyr_kinase_cat_dom | 2.89e-03 | 88 | 125 | 4 | IPR020635 | |
| Domain | TyrKc | 2.89e-03 | 88 | 125 | 4 | SM00219 | |
| Domain | PROTEIN_KINASE_ATP | 3.75e-03 | 459 | 125 | 9 | PS00107 | |
| Domain | - | 3.83e-03 | 222 | 125 | 6 | 1.25.10.10 | |
| Domain | Dynein_heavy_chain_D4_dom | 3.84e-03 | 14 | 125 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 3.84e-03 | 14 | 125 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 3.84e-03 | 14 | 125 | 2 | IPR013602 | |
| Domain | DHC_N2 | 3.84e-03 | 14 | 125 | 2 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 3.84e-03 | 14 | 125 | 2 | IPR011704 | |
| Domain | MT | 3.84e-03 | 14 | 125 | 2 | PF12777 | |
| Domain | AAA_8 | 3.84e-03 | 14 | 125 | 2 | PF12780 | |
| Domain | AAA_5 | 3.84e-03 | 14 | 125 | 2 | PF07728 | |
| Domain | PROTEIN_KINASE_TYR | 4.10e-03 | 97 | 125 | 4 | PS00109 | |
| Domain | Tyr_kinase_AS | 4.10e-03 | 97 | 125 | 4 | IPR008266 | |
| Domain | DHC_fam | 4.41e-03 | 15 | 125 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 4.41e-03 | 15 | 125 | 2 | PF03028 | |
| Domain | Dynein_heavy_dom | 4.41e-03 | 15 | 125 | 2 | IPR004273 | |
| Domain | - | 5.01e-03 | 16 | 125 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 5.01e-03 | 16 | 125 | 2 | SM00146 | |
| Domain | Cyt_P450_CS | 5.37e-03 | 53 | 125 | 3 | IPR017972 | |
| Domain | Prot_kinase_dom | 5.64e-03 | 489 | 125 | 9 | IPR000719 | |
| Domain | PI3_PI4_kinase | 6.34e-03 | 18 | 125 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 6.34e-03 | 18 | 125 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 6.34e-03 | 18 | 125 | 2 | PS00916 | |
| Domain | PI3/4_kinase_cat_dom | 6.34e-03 | 18 | 125 | 2 | IPR000403 | |
| Domain | PI3_4_KINASE_3 | 6.34e-03 | 18 | 125 | 2 | PS50290 | |
| Domain | Furin_repeat | 6.34e-03 | 18 | 125 | 2 | IPR006212 | |
| Domain | FU | 6.34e-03 | 18 | 125 | 2 | SM00261 | |
| Domain | CYTOCHROME_P450 | 6.58e-03 | 57 | 125 | 3 | PS00086 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 6.65e-06 | 39 | 97 | 5 | MM15695 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RANBP1 MYBBP1A NRDC MYO6 NOC2L POLE U2SURP SMC6 PSMC4 YTHDC2 CLASP2 NDUFV1 CDCA2 CLPTM1L JUP PPP2R2A CDC40 BAZ1A CEBPZ ANAPC1 CCAR1 RACGAP1 PRKCD PRKDC | 5.82e-10 | 1425 | 130 | 24 | 30948266 |
| Pubmed | 5.84e-09 | 104 | 130 | 8 | 9205841 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DOCK3 ABCC3 ERBB2 ABCA2 SEMA7A POLE ANXA11 PSMB10 CHSY1 FRMD8 CLASP2 LRRK1 ITGA3 TRRAP FANCA TRAPPC12 NPRL3 PRKDC TOP3B | 3.20e-08 | 1105 | 130 | 19 | 35748872 |
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 2233742 | ||
| Pubmed | Different gamma-glutamyl transpeptidase mRNAs are expressed in human liver and kidney. | 5.10e-08 | 3 | 130 | 3 | 2573352 | |
| Pubmed | ERBB2 CYP11B2 CYP26A1 CSK TRAPPC12 BAZ1A NPRL3 PRKCD PRKDC CDC25B | 9.71e-08 | 276 | 130 | 10 | 28319085 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | USP53 DOCK4 ERBB2 CLASP1 NELFCD SIK1 CLASP2 ARHGEF17 CDCA2 ARFGEF3 JUP RACGAP1 AKAP11 PAN3 RAPGEF2 CDC25B | 1.52e-07 | 861 | 130 | 16 | 36931259 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | MYBBP1A CLASP1 ATAD5 NOC2L POLE SMC6 YTHDC2 TRRAP CDCA2 CDC40 BAZ1A CEBPZ RACGAP1 PRKDC TOP3B | 1.75e-07 | 759 | 130 | 15 | 35915203 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | DOCK4 RANBP1 MYBBP1A CLASP1 MYO6 NELFCD NOC2L POLE PSMC4 CLASP2 LRRK1 TRRAP JAK1 JUP PPP2R2A PAK2 RACGAP1 AKAP11 CDC25B | 3.25e-07 | 1284 | 130 | 19 | 17353931 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | CLASP1 MYO6 U2SURP PSMC4 CHD9 YTHDC2 CLASP2 ME1 TRRAP CCAR1 TOP3B ZNF292 | 3.99e-07 | 497 | 130 | 12 | 36774506 |
| Pubmed | Reversible skeletal abnormalities in gamma-glutamyl transpeptidase-deficient mice. | 5.08e-07 | 5 | 130 | 3 | 12810527 | |
| Pubmed | Reproductive defects in gamma-glutamyl transpeptidase-deficient mice. | 5.08e-07 | 5 | 130 | 3 | 11089562 | |
| Pubmed | 5.08e-07 | 5 | 130 | 3 | 9139708 | ||
| Pubmed | 5.08e-07 | 5 | 130 | 3 | 20622017 | ||
| Pubmed | Accelerated methylmercury elimination in gamma-glutamyl transpeptidase-deficient mice. | 5.08e-07 | 5 | 130 | 3 | 9546365 | |
| Pubmed | 5.08e-07 | 5 | 130 | 3 | 7485380 | ||
| Pubmed | Accumulation of DNA damage in the organs of mice deficient in gamma-glutamyltranspeptidase. | 5.08e-07 | 5 | 130 | 3 | 10751614 | |
| Pubmed | 5.08e-07 | 5 | 130 | 3 | 10474818 | ||
| Pubmed | 5.08e-07 | 5 | 130 | 3 | 10940879 | ||
| Pubmed | 5.08e-07 | 5 | 130 | 3 | 9627710 | ||
| Pubmed | 5.08e-07 | 5 | 130 | 3 | 12453183 | ||
| Pubmed | Inhibiting lung lining fluid glutathione metabolism with GGsTop as a novel treatment for asthma. | 5.08e-07 | 5 | 130 | 3 | 25132819 | |
| Pubmed | 5.08e-07 | 5 | 130 | 3 | 23615310 | ||
| Pubmed | 5.08e-07 | 5 | 130 | 3 | 11003618 | ||
| Pubmed | 5.08e-07 | 5 | 130 | 3 | 10392451 | ||
| Pubmed | 5.08e-07 | 5 | 130 | 3 | 19850887 | ||
| Pubmed | Growth retardation and cysteine deficiency in gamma-glutamyl transpeptidase-deficient mice. | 5.08e-07 | 5 | 130 | 3 | 8755578 | |
| Pubmed | 5.08e-07 | 5 | 130 | 3 | 26977590 | ||
| Pubmed | Gamma-glutamyl transferase deficiency results in lung oxidant stress in normoxia. | 5.08e-07 | 5 | 130 | 3 | 12225953 | |
| Pubmed | 5.08e-07 | 5 | 130 | 3 | 7775425 | ||
| Pubmed | Type VI RNA is the major gamma-glutamyl transpeptidase RNA in the mouse small intestine. | 5.08e-07 | 5 | 130 | 3 | 7523374 | |
| Pubmed | Cardio-reno-hepatic interactions in acute heart failure: the role of γ-glutamyl transferase. | 5.08e-07 | 5 | 130 | 3 | 24698228 | |
| Pubmed | Lung lining fluid glutathione attenuates IL-13-induced asthma. | 5.08e-07 | 5 | 130 | 3 | 18063838 | |
| Pubmed | Cataract development in gamma-glutamyl transpeptidase-deficient mice. | 5.08e-07 | 5 | 130 | 3 | 11095909 | |
| Pubmed | 5.08e-07 | 5 | 130 | 3 | 7641802 | ||
| Pubmed | 5.08e-07 | 5 | 130 | 3 | 2891746 | ||
| Pubmed | 5.08e-07 | 5 | 130 | 3 | 28660214 | ||
| Pubmed | Bleomycin-induced pulmonary fibrosis is attenuated in gamma-glutamyl transpeptidase-deficient mice. | 5.08e-07 | 5 | 130 | 3 | 12468440 | |
| Pubmed | Cloning of cDNA and genomic structure of the mouse gamma-glutamyl transpeptidase-encoding gene. | 5.08e-07 | 5 | 130 | 3 | 8566783 | |
| Pubmed | 5.08e-07 | 5 | 130 | 3 | 30591459 | ||
| Pubmed | 5.08e-07 | 5 | 130 | 3 | 11795900 | ||
| Pubmed | Characterization of the dwg mutations: dwg and dwg(Bayer) are new mutant alleles of the Ggt1 gene. | 5.08e-07 | 5 | 130 | 3 | 19760322 | |
| Pubmed | Gene dosage in the developing and adult brain in a mouse model of 22q11 deletion syndrome. | 5.48e-07 | 18 | 130 | 4 | 17097888 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ABCC3 RANBP1 ERBB2 ABCA2 SUN1 LAMA4 CHSY1 C1RL ITGA3 DIPK2A NRP1 FANCA GRAMD1B CLPTM1L JUP PPP2R2A AK2 UBIAD1 | 5.70e-07 | 1201 | 130 | 18 | 35696571 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | ERBB2 MYBBP1A MYO6 NELFCD PDK1 POLE SUN1 PSMC4 ADCK2 YTHDC2 ELOVL2 NDUFV1 ARFGEF3 CLPTM1L CDC40 VANGL1 PRKCD AK2 AKAP11 TOP3B | 7.58e-07 | 1496 | 130 | 20 | 32877691 |
| Pubmed | Six mRNAs with different 5' ends are encoded by a single gamma-glutamyltransferase gene in mouse. | 1.01e-06 | 6 | 130 | 3 | 8101000 | |
| Pubmed | 1.01e-06 | 6 | 130 | 3 | 12163373 | ||
| Pubmed | 1.01e-06 | 6 | 130 | 3 | 22242126 | ||
| Pubmed | 1.01e-06 | 6 | 130 | 3 | 8663190 | ||
| Pubmed | 1.01e-06 | 6 | 130 | 3 | 14634009 | ||
| Pubmed | Mapping of human gamma-glutamyl transpeptidase genes on chromosome 22 and other human autosomes. | 1.01e-06 | 6 | 130 | 3 | 8104871 | |
| Pubmed | 1.01e-06 | 6 | 130 | 3 | 11463821 | ||
| Pubmed | 1.01e-06 | 6 | 130 | 3 | 25326709 | ||
| Pubmed | 1.01e-06 | 6 | 130 | 3 | 17363454 | ||
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 1.43e-06 | 212 | 130 | 8 | 33853758 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | MYBBP1A NOC2L U2SURP ANXA11 SUN1 INSR YTHDC2 TRRAP NRP1 JUP BAZ1A CEBPZ BBS7 VANGL1 RACGAP1 PRKDC | 1.50e-06 | 1024 | 130 | 16 | 24711643 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ONECUT2 MYBBP1A HIF1A ATAD5 NOC2L U2SURP TRRAP FANCA CDCA2 CDC40 BAZ1A CEBPZ ANAPC1 CCAR1 RACGAP1 ING4 NKTR PRKDC | 1.65e-06 | 1294 | 130 | 18 | 30804502 |
| Pubmed | Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation. | 1.77e-06 | 7 | 130 | 3 | 32284594 | |
| Pubmed | 1.77e-06 | 7 | 130 | 3 | 36685533 | ||
| Pubmed | Defective epidermal growth factor gene expression in mice with polycystic kidney disease. | 1.77e-06 | 7 | 130 | 3 | 1968405 | |
| Pubmed | 1.77e-06 | 7 | 130 | 3 | 27775020 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | MYBBP1A SEMA7A IFT172 YTHDC2 CLASP2 PREX2 PPP2R2A RAPGEF2 TOP3B KCNT1 INPP5J | 1.86e-06 | 475 | 130 | 11 | 31040226 |
| Pubmed | 2.02e-06 | 222 | 130 | 8 | 35941108 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | MPP2 MYBBP1A CLASP1 POLE U2SURP ANXA11 PSMC4 YTHDC2 CSK ANAPC1 RACGAP1 PRKDC | 2.07e-06 | 582 | 130 | 12 | 20467437 |
| Pubmed | 2.12e-06 | 156 | 130 | 7 | 22952844 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | MYBBP1A ATAD5 NOC2L U2SURP CHD9 TRRAP BAZ1A ANAPC1 RACGAP1 PRKDC | 2.48e-06 | 394 | 130 | 10 | 27248496 |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | MYBBP1A MYO6 NOC2L POLE SUN1 PSMC4 CHSY1 BTBD1 NDUFV1 DIPK2A FANCA ARFGEF3 CEBPZ PRKDC UBIAD1 | 2.59e-06 | 942 | 130 | 15 | 31073040 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RANBP1 MYBBP1A IL18 MYO6 NOC2L POLE U2SURP PSMC4 TRRAP CDCA2 JUP CDC40 BAZ1A CEBPZ CCAR1 RACGAP1 PRKCD PRKDC | 3.08e-06 | 1353 | 130 | 18 | 29467282 |
| Pubmed | RANBP1 MYBBP1A HIF1A MYO6 U2SURP INSR PSMC4 CHD9 CLASP2 ME1 DNAH1 JUP PPP2R2A CEBPZ NPRL3 RACGAP1 PRKDC | 4.30e-06 | 1247 | 130 | 17 | 27684187 | |
| Pubmed | NOL4 ERBB2 ATAD5 CHD9 YTHDC2 ITGA3 TRRAP JAK1 PPP2R2A COQ8A PRPF40B ANAPC1 VANGL1 ING4 RAPGEF2 SP140 | 4.49e-06 | 1116 | 130 | 16 | 31753913 | |
| Pubmed | USP53 ERBB2 ABCA2 SUN1 CHSY1 LRRK1 PPP2R2A COQ8A RACGAP1 AKAP11 KCNT1 | 5.18e-06 | 529 | 130 | 11 | 14621295 | |
| Pubmed | 6.01e-06 | 10 | 130 | 3 | 23863468 | ||
| Pubmed | RANBP1 NRDC U2SURP PSMC4 ITGA3 ARHGEF17 TRRAP NDUFV1 JAK1 CLPTM1L JUP BAZ1A VANGL1 CCAR1 RACGAP1 PRKDC TOP3B | 7.20e-06 | 1297 | 130 | 17 | 33545068 | |
| Pubmed | RANBP1 MYBBP1A NELFCD NOC2L SPEF2 U2SURP SIK1 H3-4 CDCA2 RGS14 BAZ1A CEBPZ PAEP CCAR1 PRKDC ABCC2 TOP3B ZNF292 | 7.38e-06 | 1442 | 130 | 18 | 35575683 | |
| Pubmed | MYBBP1A MYO6 ATAD5 NOC2L PDK1 POLE SUN1 PSMC4 CLASP2 NDUFV1 GRAMD1B CLPTM1L JUP CEBPZ BBS7 VANGL1 AKAP11 TOP3B | 1.12e-05 | 1487 | 130 | 18 | 33957083 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | USP53 ERBB2 HIF1A MYO6 FOLH1 INSR CHD9 CLASP2 TRRAP ADCY3 DNAH1 NRP1 ARFGEF3 PPP2R2A COQ8A CCAR1 PAN3 RAPGEF2 | 1.14e-05 | 1489 | 130 | 18 | 28611215 |
| Pubmed | 1.25e-05 | 38 | 130 | 4 | 27820600 | ||
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | MYBBP1A POLE U2SURP YTHDC2 JAK1 JUP PPP2R2A CSK BAZ1A CCAR1 PRKDC | 1.29e-05 | 583 | 130 | 11 | 29844126 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | ONECUT2 NOL4 MYBBP1A ROGDI CLASP1 PDK1 U2SURP CHD9 TRRAP NDUFV1 CDC40 CCAR1 PRKDC PAN3 ZNF292 | 1.35e-05 | 1082 | 130 | 15 | 38697112 |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 16914514 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 35012455 | ||
| Pubmed | Role of genetic variation in regulation of aldosterone biosynthesis. | 1.39e-05 | 2 | 130 | 2 | 21164264 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 20634641 | ||
| Pubmed | Apoptotic phosphorylation of histone H3 on Ser-10 by protein kinase Cδ. | 1.39e-05 | 2 | 130 | 2 | 22984491 | |
| Pubmed | Vasculogenic mimicry of HT1080 tumour cells in vivo: critical role of HIF-1α-neuropilin-1 axis. | 1.39e-05 | 2 | 130 | 2 | 23185562 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 29464551 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 1741400 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 22933298 | ||
| Pubmed | Molecular genetic studies on the biosynthesis of aldosterone in humans. | 1.39e-05 | 2 | 130 | 2 | 22217843 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 20651983 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 28339028 | ||
| Pubmed | [123 I]Iodometomidate for molecular imaging of adrenocortical cytochrome P450 family 11B enzymes. | 1.39e-05 | 2 | 130 | 2 | 18397978 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 23761669 | ||
| Pubmed | Evidence for local aldosterone synthesis in the large intestine of the mouse. | 1.39e-05 | 2 | 130 | 2 | 35288482 | |
| Pubmed | Homeostatic responses in the adrenal cortex to the absence of aldosterone in mice. | 1.39e-05 | 2 | 130 | 2 | 15731365 | |
| Pubmed | Inactivation of DNA-dependent protein kinase by protein kinase Cdelta: implications for apoptosis. | 1.39e-05 | 2 | 130 | 2 | 9774685 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 17651452 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 20808686 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 25788542 | ||
| Pubmed | Human CLASP1 is an outer kinetochore component that regulates spindle microtubule dynamics. | 1.39e-05 | 2 | 130 | 2 | 12837247 | |
| Interaction | ERMAP interactions | 8.35e-07 | 28 | 128 | 5 | int:ERMAP | |
| Interaction | FGF8 interactions | 5.79e-06 | 108 | 128 | 7 | int:FGF8 | |
| Interaction | YWHAG interactions | USP53 DOCK4 CLASP1 NELFCD SIK1 CLASP2 ARHGEF17 TRRAP CDCA2 JUP CSK BAZ1A PAK2 RACGAP1 ING4 PRKCD AKAP11 NKTR PRKDC PAN3 RAPGEF2 CDC25B | 1.18e-05 | 1248 | 128 | 22 | int:YWHAG |
| Interaction | GRK5 interactions | 2.16e-05 | 182 | 128 | 8 | int:GRK5 | |
| GeneFamily | CD molecules|Gamma-glutamyltransferases | 3.29e-05 | 13 | 90 | 3 | 564 | |
| GeneFamily | Cytochrome P450 family 11 | 7.33e-05 | 3 | 90 | 2 | 1007 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.88e-04 | 181 | 90 | 6 | 694 | |
| GeneFamily | ATP binding cassette subfamily C | 1.84e-03 | 13 | 90 | 2 | 807 | |
| GeneFamily | Dyneins, axonemal | 3.17e-03 | 17 | 90 | 2 | 536 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 3.51e-03 | 394 | 90 | 7 | 471 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 4.39e-03 | 20 | 90 | 2 | 548 | |
| GeneFamily | Bardet-Biedl syndrome associated|BBSome | 4.84e-03 | 21 | 90 | 2 | 980 | |
| Coexpression | GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN | 1.84e-06 | 166 | 130 | 8 | M8129 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | RAD51C DOCK4 HIF1A CLASP1 U2SURP CHSY1 CHD9 CLASP2 TRRAP ELOVL2 PPP2R2A BAZ1A ARNT2 AKAP11 RAPGEF2 ZNF292 | 5.49e-06 | 856 | 130 | 16 | M4500 |
| Coexpression | GSE37534_GW1929_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_UP | 6.80e-06 | 198 | 130 | 8 | M8985 | |
| Coexpression | HALLMARK_E2F_TARGETS | 7.32e-06 | 200 | 130 | 8 | M5925 | |
| Coexpression | GSE39916_B_CELL_SPLEEN_VS_PLASMA_CELL_BONE_MARROW_DN | 7.32e-06 | 200 | 130 | 8 | M9272 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | IL18 SHFL ANXA11 SUN1 PSMC4 DENND1C BTBD2 TRRAP NDUFV1 DNAH1 JAK1 NPRL3 PRKCD PLCB2 NKTR TOP3B | 1.10e-05 | 905 | 130 | 16 | M40865 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN | IL18 SHFL ANXA11 SUN1 PSMC4 BTBD2 NDUFV1 DNAH1 JAK1 NPRL3 PRKCD PLCB2 NKTR | 1.69e-05 | 634 | 130 | 13 | M40866 |
| Coexpression | ROZANOV_MMP14_TARGETS_SUBSET | 2.11e-05 | 33 | 130 | 4 | M9167 | |
| Coexpression | GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_24H_INCUBATION_DN | 6.09e-05 | 198 | 130 | 7 | M6578 | |
| Coexpression | GSE12845_IGD_NEG_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN | 6.09e-05 | 198 | 130 | 7 | M3195 | |
| Coexpression | GSE33424_CD161_HIGH_VS_NEG_CD8_TCELL_DN | 6.29e-05 | 199 | 130 | 7 | M8542 | |
| Coexpression | GSE13493_DP_VS_CD8POS_THYMOCYTE_DN | 6.49e-05 | 200 | 130 | 7 | M3315 | |
| Coexpression | GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_UP | 6.49e-05 | 200 | 130 | 7 | M7430 | |
| Coexpression | GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_LN_DN | 6.49e-05 | 200 | 130 | 7 | M8958 | |
| Coexpression | GSE22432_PDC_VS_TGFB1_TREATEDCOMMON_DC_PROGENITOR_DN | 6.49e-05 | 200 | 130 | 7 | M7833 | |
| Coexpression | GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_UP | 6.49e-05 | 200 | 130 | 7 | M5777 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | CLASP1 U2SURP CHSY1 CHD9 CLASP2 TRRAP PPP2R2A BAZ1A RAPGEF2 ZNF292 | 1.14e-04 | 466 | 130 | 10 | M13522 |
| ToppCell | tumor_Lung-Epithelial_cells-tS2|tumor_Lung / Location, Cell class and cell subclass | 1.30e-07 | 199 | 130 | 8 | 28ec59e01061287fb0892491790b316e2b93e232 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD8-Tem/emra_CD8|GI_large-bowel / Manually curated celltypes from each tissue | 5.92e-07 | 166 | 130 | 7 | 13bef304ea3df8e8d2bc376a3287c78220a1b0c6 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-B-CD5+_CCL22+_mature_B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.18e-06 | 184 | 130 | 7 | 5bb775253a10a14360b06a46aba46d162a9bd1f8 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasmablast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.74e-06 | 195 | 130 | 7 | a045fb8a377e54fb57fef1181d4c3fc15d627ef6 | |
| ToppCell | Tracheal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.86e-06 | 197 | 130 | 7 | 06e17c9ad53463eee1007280b3f3e8b0cf446cdc | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 1.99e-06 | 199 | 130 | 7 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | LPS-antiTNF-Lymphocytic_B|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.23e-05 | 174 | 130 | 6 | cc493654ea3517bc6a145c7f787f304929636f86 | |
| ToppCell | LPS-antiTNF-Lymphocytic_B-B_cells-B-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.23e-05 | 174 | 130 | 6 | 9eb3504f9340517ef5d056503044fbdb9ffeb714 | |
| ToppCell | LPS-antiTNF-Lymphocytic_B-B_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.23e-05 | 174 | 130 | 6 | b4c2d1c029fcd0d4926aa79a5b789c713919dcf3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-05 | 177 | 130 | 6 | 2f81b26be89cc2fd8eafadaf7eae3c6ad6521462 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-05 | 182 | 130 | 6 | 4a9c13932e7163fd37a3dcc4c6ca3bbea5372459 | |
| ToppCell | facs-Kidney-nan-3m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-05 | 182 | 130 | 6 | 4c5d14e33ebdf117b5aa9e2f57aaa89aa51f72bf | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 184 | 130 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 184 | 130 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 184 | 130 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Control-Epithelial-Club|Epithelial / Disease state, Lineage and Cell class | 1.74e-05 | 185 | 130 | 6 | 6814b3c94c7558443c038a227b5c8563d2cfeac4 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|lung / Disease (COVID-19 only), tissue and cell type | 1.80e-05 | 186 | 130 | 6 | 66676d9395172de5707e204826a1c9f73b448cca | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.80e-05 | 186 | 130 | 6 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-B-CD5+_CCL22-_mature_B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.80e-05 | 186 | 130 | 6 | 3941d4af5f2b209d71f59d7d920f2322131b4a0c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-05 | 186 | 130 | 6 | a417e1e21313a7e05951038cdef5ac672a9f727c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-05 | 187 | 130 | 6 | 87b3d0478693d4c54ff06b74e5903036b9c1ee6a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-05 | 187 | 130 | 6 | 42a1267bfc27b4460b8409ada580a87c4385841c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-05 | 187 | 130 | 6 | 64afdea159f5e67a1e5cea35ce898aae6e80aea5 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.09e-05 | 191 | 130 | 6 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-05 | 191 | 130 | 6 | 9032aa974aa1b7b1095b8d1b58dcb087358a5001 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-05 | 191 | 130 | 6 | 5717809a1476c20f65bce722c5a57cff92ee0d7a | |
| ToppCell | Ciliated-cil-3|World / Class top | 2.15e-05 | 192 | 130 | 6 | 4989ebb8812b8af1870599acd932849122c05a29 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-05 | 192 | 130 | 6 | 8b86db2ebe0199fee0e9800566a619a24bfdeed5 | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-aorta_endothelial_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-05 | 195 | 130 | 6 | 3969b8d5fcec8ef1831531a781f7bbcebab5a4ba | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.48e-05 | 197 | 130 | 6 | 0f489d26e4013d1b5a90559856ed2de32a0bb772 | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-NK_CD56bright|IIF / Disease, condition lineage and cell class | 2.63e-05 | 199 | 130 | 6 | 9eb2b7d4900b118338590db778a47504559e228d | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 2.63e-05 | 199 | 130 | 6 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 2.63e-05 | 199 | 130 | 6 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | tumor_Lung-Epithelial_cells|tumor_Lung / Location, Cell class and cell subclass | 2.63e-05 | 199 | 130 | 6 | 56b3f6c8b561d60780d91daf6b44a9dcf616e599 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 2.63e-05 | 199 | 130 | 6 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.63e-05 | 199 | 130 | 6 | 89d7622c4ae146900d963ac68c6bf011e8674665 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.70e-05 | 200 | 130 | 6 | 0de9e7412a1725a8acd51820aa3135a112ced36c | |
| ToppCell | Calu_3|World / Cell line, Condition and Strain | 2.70e-05 | 200 | 130 | 6 | a549aa08aeefe905653266dae3936094ff55f8e4 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-cDC1|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.89e-05 | 150 | 130 | 5 | 3dc23a37dbeb7f9df93683702a7838f7cc3ec9cc | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-Plasma_B-Plasma_B-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.78e-05 | 157 | 130 | 5 | 63502d0fd5972d71cdbe13bde167592c70acec32 | |
| ToppCell | IIF-Lymphocyte-T_NK-NK_CD56bright|IIF / Disease, Lineage and Cell Type | 1.10e-04 | 161 | 130 | 5 | b1bd1074ecba4cf171d748e2f686e9a99c0f0e89 | |
| ToppCell | PND01-03-samps|World / Age Group, Lineage, Cell class and subclass | 1.10e-04 | 161 | 130 | 5 | 1973b112d8d67aacc02751797d0148e7b53bfa66 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.13e-04 | 162 | 130 | 5 | 388670cf3acef17df971c0d8ae3ce14398945192 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-DC-cDC1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.13e-04 | 162 | 130 | 5 | 9333d923225df7bfdf6b3a4c32816751315aec50 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-04 | 163 | 130 | 5 | bbc078761c5043af13d9a6fcf3145a3e300bae5e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-04 | 163 | 130 | 5 | 8e32b6431e1862572663aa6ddc4ea299c6acc8a6 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-04 | 164 | 130 | 5 | d2218d50e0e2d19f919dcb460b3840687c082810 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells-B-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-04 | 168 | 130 | 5 | eeb381b62c7ba263af96de1194ed59e57b6ca3ae | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-04 | 168 | 130 | 5 | 063d0368d656962b335154c230bdcd9236e7c9ad | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-04 | 168 | 130 | 5 | a7c4251d8a83bc30196a444028a35c17c24dc291 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-04 | 169 | 130 | 5 | b253a4a50c06d36228fcd5d856c57202cbac158f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-04 | 169 | 130 | 5 | e7514956b2e4298222ec443f98b2f5289451786e | |
| ToppCell | LPS-IL1RA-Lymphocytic_B-B_cells-B-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.42e-04 | 170 | 130 | 5 | 92e0873f618b2fa60c4d555b10f234d5cbcf3325 | |
| ToppCell | LPS-IL1RA-Lymphocytic_B-B_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.42e-04 | 170 | 130 | 5 | c181991f933b779f99afc3782f292306f209e2ac | |
| ToppCell | LPS-IL1RA-Lymphocytic_B|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.42e-04 | 170 | 130 | 5 | 56284fbfd1e53f67c8c0b7fba64505a4002adba2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-04 | 171 | 130 | 5 | f5014e3c387fe3118944af392abe10d6b9b0abab | |
| ToppCell | Adult-Immune-B_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.46e-04 | 171 | 130 | 5 | 355a246f3395900342d400f6f7c6640cba0d4d5d | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.50e-04 | 172 | 130 | 5 | 03a0aff6b7971093a4347b5ed12546d78374c56f | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.50e-04 | 172 | 130 | 5 | 7c238a7375341d4647ba7274d93fddfb6fae7ce4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 173 | 130 | 5 | 62ba49c1c16760a8c6cde0cc44e068f94386946a | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-B-CD5+_CCL22+_mature_B|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.63e-04 | 175 | 130 | 5 | fa53ea81ad943a2cd266114829135cbcbcf2f634 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-04 | 175 | 130 | 5 | 9a96a946db731ba24c9be34bedebf1f4a1372b9e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-04 | 175 | 130 | 5 | 54c1f080195ad8392a095e83b56a4b54073d4c0d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-04 | 175 | 130 | 5 | 2b51406a2c2daa13ab4ed283ede038cd11d9e641 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 176 | 130 | 5 | 24b2e94ee5defcefb64a1f2447a2cc71b015b0fd | |
| ToppCell | Adult-Immune-B_cell|Adult / Lineage, Cell type, age group and donor | 1.67e-04 | 176 | 130 | 5 | 4aa00dcde907ad83d3aa4bb10439b7b5c4be1e5d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-04 | 176 | 130 | 5 | 1595dbeee336a81e581325d63208ec6262664ee9 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.71e-04 | 177 | 130 | 5 | f360f7099570d248531897b96e0de282e58f59e9 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 177 | 130 | 5 | ac0cf03e2a1baf84db3ae245d59bbc6ae52c13be | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-04 | 178 | 130 | 5 | 888add8935ef3aef9b6693c5698e9d1842e66337 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-04 | 178 | 130 | 5 | 43eda32af2e5e28a92421612d0a4c21e5427a772 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.81e-04 | 179 | 130 | 5 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | Children_(3_yrs)-Immune-B_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.85e-04 | 180 | 130 | 5 | 40a12eb852373ae3d7c8d9bca376b0ae99f724b3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-04 | 180 | 130 | 5 | 1363b3254470f6ff98630d1df83a1bdbacc137e0 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-APOE+_Mac2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.85e-04 | 180 | 130 | 5 | c630a121aedd09a51ea18cc6e8552eb979e5b555 | |
| ToppCell | facs-Heart-LV-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-04 | 182 | 130 | 5 | 6dff753d65ba45db81f3cc0c9f59e1779d490955 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_B_plasma-Plasma_cells|GI_small-bowel / Manually curated celltypes from each tissue | 2.00e-04 | 183 | 130 | 5 | ab5aaafcfd7b97330be6774be4c72611ca85257c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-04 | 183 | 130 | 5 | 84b64cf728629c3af9a8d2ed15b93adf562c54b8 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 2.00e-04 | 183 | 130 | 5 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_B_plasma|GI_small-bowel / Manually curated celltypes from each tissue | 2.00e-04 | 183 | 130 | 5 | 193bfb787c1b36c8fabf4b00fafb5b398de6b999 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.00e-04 | 183 | 130 | 5 | 62f76907e501bba6e1010b5c447faed5f0ef93a7 | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.00e-04 | 183 | 130 | 5 | a716b446c2bf5aa294b8f580aa845098fae76354 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_int|lung / Disease (COVID-19 only), tissue and cell type | 2.05e-04 | 184 | 130 | 5 | 480595a0e2e6aa2a77b7daa36490ae3af3d8dfee | |
| ToppCell | nucseq-Immune-Lymphocytic_B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.05e-04 | 184 | 130 | 5 | 911658e7bb499c1bbc8419eec8ff88729bc39a75 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.05e-04 | 184 | 130 | 5 | ed7a8e79e5723a5f5a03f542203d9e50bdef5f50 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.05e-04 | 184 | 130 | 5 | fe9ea4d0e0be820e95eaf9bb42a5560d0e177574 | |
| ToppCell | CV-Healthy-7|CV / Virus stimulation, Condition and Cluster | 2.05e-04 | 184 | 130 | 5 | 0e5cc77aaa73ceb791f8be7456177577fd2e5586 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-B-CD5+_CCL22-_mature_B|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.05e-04 | 184 | 130 | 5 | 18aa9c43b79d12c9e420dfd9822745c022be6789 | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.05e-04 | 184 | 130 | 5 | 942b58ae7172bb5f97e55b032db9329d161854af | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 2.10e-04 | 185 | 130 | 5 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | LA-07._Pericyte|LA / Chamber and Cluster_Paper | 2.10e-04 | 185 | 130 | 5 | ba5baa4d7f097108622674de5b7f4fd279843d24 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.16e-04 | 186 | 130 | 5 | bdd9d3a432aab46e733469b362f0064d35c1ac49 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-B_cells-Immature_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.16e-04 | 186 | 130 | 5 | 459a7e97bbac2b2cd253aa4ab38d0e4ae6191e8b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-04 | 186 | 130 | 5 | 8287146f0ba415ea04475588117d4668ae00f75c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-04 | 186 | 130 | 5 | b1edc341d6684b347dc9e21b34f62f51d095d735 | |
| ToppCell | Control-Lymphoid-B_Plasma|Lymphoid / Disease state, Lineage and Cell class | 2.16e-04 | 186 | 130 | 5 | a08a50bff4e629588faa22440d57334b1df0e8df | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-04 | 187 | 130 | 5 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.21e-04 | 187 | 130 | 5 | 9042bd0f57213a51503d9df2e4dce3209b7772d3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-04 | 187 | 130 | 5 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-04 | 187 | 130 | 5 | 1b82920588f9e26ef1db244d452736d75fcfd342 | |
| Drug | Mercuric Chloride | ABCC3 RANBP1 HIF1A NELFCD U2SURP PSMC4 SIK1 BTBD2 ME1 NDUFV1 GGT1 CDCA2 GRAMD1B JAK1 ARFGEF3 JUP BAZ1A ARNT2 ING4 AK2 ABCC2 | 2.40e-06 | 1155 | 130 | 21 | ctd:D008627 |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 9.34e-06 | 180 | 130 | 8 | 4541_DN | |
| Drug | 17-isoprogesterone | ERBB2 HIF1A ABCA2 IL18 ROGDI CYP11B1 CYP11B2 ANXA11 CYP26A1 INSR YTHDC2 GRM4 ADCY3 GGT1 CSK BBS7 PAEP NPRL3 PRKCD ABCC2 | 1.07e-05 | 1170 | 130 | 20 | CID000004920 |
| Drug | Molindone hydrochloride [15622-65-8]; Down 200; 12.8uM; PC3; HT_HG-U133A | 1.67e-05 | 195 | 130 | 8 | 4199_DN | |
| Drug | Cefoxitin sodium salt [33564-30-6]; Up 200; 8.8uM; HL60; HT_HG-U133A | 1.73e-05 | 196 | 130 | 8 | 2735_UP | |
| Drug | Acetohexamide [968-81-0]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 1.80e-05 | 197 | 130 | 8 | 7482_UP | |
| Drug | 6-Furfurylaminopurine [525-79-1]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 1.86e-05 | 198 | 130 | 8 | 6073_DN | |
| Drug | Spironolactone | 2.80e-05 | 103 | 130 | 6 | ctd:D013148 | |
| Drug | 5(6)-carboxy-2',7'-dichlorofluorescein | 3.24e-05 | 2 | 130 | 2 | ctd:C053897 | |
| Drug | cyadox | 3.24e-05 | 2 | 130 | 2 | ctd:C020728 | |
| Drug | 18-hydroxydeoxycorticosterone | 3.24e-05 | 2 | 130 | 2 | ctd:C042509 | |
| Drug | E3040 glucuronide | 3.24e-05 | 2 | 130 | 2 | CID000443294 | |
| Drug | 3,4,5,3',4',5'-hexachlorobiphenyl | 4.99e-05 | 13 | 130 | 3 | ctd:C027309 | |
| Drug | 1H,1H,2H,2H-perfluorodecanol | 4.99e-05 | 13 | 130 | 3 | ctd:C033729 | |
| Drug | dichloromethanediamine | RAD51C ABCC3 ERBB2 HIF1A HECW1 GGT1 FANCA PAK2 PRKCD PRKDC ABCC2 TOP3B | 6.28e-05 | 539 | 130 | 12 | CID005311048 |
| Drug | 21-deoxycortisol | 7.15e-05 | 39 | 130 | 4 | CID000092827 | |
| Drug | platinum | 8.89e-05 | 183 | 130 | 7 | CID000023939 | |
| Drug | Bortezomib | USP53 ERBB2 HIF1A ABCA2 HECW1 SMC6 PSMC4 ME1 TRRAP JAK1 PPP2R2A CCAR1 PRKCD PRKDC ABCC2 | 8.98e-05 | 838 | 130 | 15 | ctd:D000069286 |
| Drug | 18-hydroxycortisol | 9.67e-05 | 3 | 130 | 2 | ctd:C033689 | |
| Drug | E3040 sulfate | 9.67e-05 | 3 | 130 | 2 | CID000443293 | |
| Drug | 5-carboxyfluorescein diacetate | 9.67e-05 | 3 | 130 | 2 | ctd:C084577 | |
| Drug | Curcumin | ERBB2 HIF1A IL18 TNC PDK1 POLE H3-4 GGT1 JAK1 CSK CCAR1 PAK2 PRKCD PRKDC ABCC2 | 1.05e-04 | 850 | 130 | 15 | ctd:D003474 |
| Drug | NSC-364372 | RANBP1 HIF1A HECW1 NRDC TRRAP FANCA JAK1 RGS14 ARNT2 NPRL3 CDC25B | 1.07e-04 | 484 | 130 | 11 | CID000435143 |
| Drug | 17-DMAG; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.20e-04 | 192 | 130 | 7 | 993_DN | |
| Drug | Probenecid [57-66-9]; Down 200; 14uM; MCF7; HT_HG-U133A | 1.24e-04 | 193 | 130 | 7 | 2825_DN | |
| Drug | Clotrimazole [23593-75-1]; Down 200; 11.6uM; PC3; HT_HG-U133A | 1.24e-04 | 193 | 130 | 7 | 5726_DN | |
| Drug | Tetrahydroalstonine [6474-90-4]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 1.24e-04 | 193 | 130 | 7 | 6209_UP | |
| Drug | Simvastatin | ABCC3 HIF1A IL18 TNC CYP11B1 CYP11B2 NRP1 JAK1 CEBPZ RACGAP1 ABCC2 CDC25B | 1.27e-04 | 581 | 130 | 12 | ctd:D019821 |
| Drug | splitomicin; Up 200; 20uM; PC3; HG-U133A | 1.28e-04 | 194 | 130 | 7 | 661_UP | |
| Drug | Fludrocortisone acetate [514-36-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 1.28e-04 | 194 | 130 | 7 | 3977_DN | |
| Drug | diosmetin | 1.28e-04 | 85 | 130 | 5 | CID005281612 | |
| Drug | CP-320650-01 [172079-28-6]; Up 200; 10uM; PC3; HT_HG-U133A | 1.32e-04 | 195 | 130 | 7 | 4557_UP | |
| Drug | Fusaric acid [536-69-6]; Up 200; 22.4uM; PC3; HT_HG-U133A | 1.36e-04 | 196 | 130 | 7 | 3986_UP | |
| Drug | Cephapirin sodium salt [24356-60-3]; Down 200; 9uM; PC3; HT_HG-U133A | 1.36e-04 | 196 | 130 | 7 | 7142_DN | |
| Drug | sodium 4-phenylbutyrate; Up 200; 1000uM; HL60; HG-U133A | 1.36e-04 | 196 | 130 | 7 | 411_UP | |
| Drug | Heliotrine [303-33-3]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 1.36e-04 | 196 | 130 | 7 | 4739_DN | |
| Drug | PHA-00851261E [724719-49-7]; Down 200; 1uM; MCF7; HT_HG-U133A | 1.36e-04 | 196 | 130 | 7 | 3857_DN | |
| Drug | mPEG | 1.38e-04 | 46 | 130 | 4 | CID000008019 | |
| Drug | Prostaglandin E1; Up 200; 10uM; MCF7; HT_HG-U133A | 1.41e-04 | 197 | 130 | 7 | 6576_UP | |
| Drug | CP-645525-01 [287190-82-3]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.41e-04 | 197 | 130 | 7 | 7522_DN | |
| Drug | aspirin, USP; Down 200; 100uM; HL60; HT_HG-U133A | 1.41e-04 | 197 | 130 | 7 | 1145_DN | |
| Drug | Quinethazone [73-49-4]; Up 200; 13.8uM; PC3; HT_HG-U133A | 1.45e-04 | 198 | 130 | 7 | 4529_UP | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HT_HG-U133A | 1.45e-04 | 198 | 130 | 7 | 5220_DN | |
| Drug | Quinic acid [86-68-0]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 1.45e-04 | 198 | 130 | 7 | 6019_DN | |
| Drug | Dicumarol [66-76-2]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.45e-04 | 198 | 130 | 7 | 3941_UP | |
| Drug | Ethacrynic acid [58-54-8]; Down 200; 13.2uM; PC3; HT_HG-U133A | 1.45e-04 | 198 | 130 | 7 | 5742_DN | |
| Drug | Aceclofenac [89796-99-6]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 1.45e-04 | 198 | 130 | 7 | 2281_UP | |
| Drug | Cefuroxime sodium salt [56238-63-2]; Down 200; 9uM; MCF7; HT_HG-U133A | 1.45e-04 | 198 | 130 | 7 | 6261_DN | |
| Drug | Netilmicin sulfate [56931-57-2]; Down 200; 2.8uM; PC3; HT_HG-U133A | 1.45e-04 | 198 | 130 | 7 | 7302_DN | |
| Drug | Nafcillin sodium salt monohydrate [7177-50-6]; Up 200; 8.8uM; HL60; HT_HG-U133A | 1.45e-04 | 198 | 130 | 7 | 2983_UP | |
| Drug | Trimethylcolchicinic acid [3482-37-9]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 1.50e-04 | 199 | 130 | 7 | 2802_DN | |
| Drug | Ketoconazole [65277-42-1]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 1.50e-04 | 199 | 130 | 7 | 2640_UP | |
| Drug | Butamben [94-25-7]; Up 200; 20.6uM; MCF7; HT_HG-U133A | 1.50e-04 | 199 | 130 | 7 | 6093_UP | |
| Drug | 17alpha-estradiol | RAD51C ABCC3 ERBB2 HIF1A CYP11B1 CYP11B2 POLE INSR CHSY1 CHD9 ITGA3 ADCY3 TLR3 NPRL3 PRKCD PLCB2 PRKDC ABCC2 KCNT1 | 1.52e-04 | 1303 | 130 | 19 | CID000000450 |
| Drug | Tiabendazole [148-79-8]; Up 200; 19.8uM; PC3; HT_HG-U133A | 1.54e-04 | 200 | 130 | 7 | 4579_UP | |
| Drug | AC1L1O6Q | 1.61e-04 | 141 | 130 | 6 | CID000058035 | |
| Drug | Apa-sg | 1.65e-04 | 19 | 130 | 3 | CID000126348 | |
| Disease | Prostatic Neoplasms | ONECUT2 ERBB2 MYBBP1A HIF1A IL18 FOLH1 CYP11B2 GGT1 NRP1 JAK1 CLPTM1L JUP PPP2R2A PRKDC ZNF292 | 6.41e-08 | 616 | 126 | 15 | C0033578 |
| Disease | Malignant neoplasm of prostate | ONECUT2 ERBB2 MYBBP1A HIF1A IL18 FOLH1 CYP11B2 GGT1 NRP1 JAK1 CLPTM1L JUP PPP2R2A PRKDC ZNF292 | 6.41e-08 | 616 | 126 | 15 | C0376358 |
| Disease | aflatoxins-related hepatocellular carcinoma (biomarker_via_orthology) | 2.63e-06 | 7 | 126 | 3 | DOID:5022 (biomarker_via_orthology) | |
| Disease | alcohol dependence (biomarker_via_orthology) | 4.19e-06 | 8 | 126 | 3 | DOID:0050741 (biomarker_via_orthology) | |
| Disease | ovarian cancer (is_implicated_in) | 4.21e-06 | 56 | 126 | 5 | DOID:2394 (is_implicated_in) | |
| Disease | Glucocorticoid-remediable aldosteronism | 1.81e-05 | 2 | 126 | 2 | C1260386 | |
| Disease | adrenal cortical adenoma (is_marker_for) | 1.81e-05 | 2 | 126 | 2 | DOID:0050891 (is_marker_for) | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 3.04e-05 | 139 | 126 | 6 | DOID:3908 (is_implicated_in) | |
| Disease | hepatocellular carcinoma (is_marker_for) | 4.74e-05 | 301 | 126 | 8 | DOID:684 (is_marker_for) | |
| Disease | Colorectal Carcinoma | ABCC3 DNAH3 FOLH1 POLE SLC1A7 PREX2 CHST8 ABCD4 CCAR1 ING4 ABCC2 ZNF292 | 4.93e-05 | 702 | 126 | 12 | C0009402 |
| Disease | congenital adrenal hyperplasia (implicated_via_orthology) | 5.41e-05 | 3 | 126 | 2 | DOID:0050811 (implicated_via_orthology) | |
| Disease | hypertension | 5.44e-05 | 307 | 126 | 8 | EFO_0000537 | |
| Disease | basophil count, eosinophil count | 8.23e-05 | 241 | 126 | 7 | EFO_0004842, EFO_0005090 | |
| Disease | urate measurement | MPP2 DOCK3 NOL4 DNAH3 POLE U2SURP INSR FRMD8 DNAH1 RGS14 COQ8A PRKCD TSGA10IP | 1.23e-04 | 895 | 126 | 13 | EFO_0004531 |
| Disease | granulocyte percentage of myeloid white cells | 1.59e-04 | 268 | 126 | 7 | EFO_0007997 | |
| Disease | primary hyperaldosteronism (is_implicated_in) | 1.79e-04 | 5 | 126 | 2 | DOID:446 (is_implicated_in) | |
| Disease | cholangiocarcinoma, sclerosing cholangitis | 1.79e-04 | 5 | 126 | 2 | EFO_0004268, EFO_0005221 | |
| Disease | Hodgkins lymphoma, multiple myeloma, chronic lymphocytic leukemia | 2.30e-04 | 28 | 126 | 3 | EFO_0000095, EFO_0000183, EFO_0001378 | |
| Disease | Conn Syndrome | 2.68e-04 | 6 | 126 | 2 | C1384514 | |
| Disease | Hyperaldosteronism | 2.68e-04 | 6 | 126 | 2 | C0020428 | |
| Disease | monocyte percentage of leukocytes | ZYG11A SPEF2 CYP26A1 CHSY1 CHD9 FANCA JAK1 KLHL5 COQ8A PRKDC PAN3 | 3.09e-04 | 731 | 126 | 11 | EFO_0007989 |
| Disease | protocadherin alpha-7 measurement | 3.75e-04 | 7 | 126 | 2 | EFO_0801973 | |
| Disease | progressive familial intrahepatic cholestasis (is_implicated_in) | 3.75e-04 | 7 | 126 | 2 | DOID:0070221 (is_implicated_in) | |
| Disease | Trypanosoma cruzi seropositivity | 3.75e-04 | 7 | 126 | 2 | EFO_0005530 | |
| Disease | skeletal age | 3.75e-04 | 7 | 126 | 2 | EFO_0020898 | |
| Disease | bilirubin metabolic disorder (biomarker_via_orthology) | 3.75e-04 | 7 | 126 | 2 | DOID:2741 (biomarker_via_orthology) | |
| Disease | fatty liver disease (biomarker_via_orthology) | 3.78e-04 | 33 | 126 | 3 | DOID:9452 (biomarker_via_orthology) | |
| Disease | nephroblastoma (is_marker_for) | 4.13e-04 | 34 | 126 | 3 | DOID:2154 (is_marker_for) | |
| Disease | Sarcoidosis | 4.98e-04 | 8 | 126 | 2 | C0036202 | |
| Disease | eosinophil percentage of granulocytes | 5.20e-04 | 234 | 126 | 6 | EFO_0007996 | |
| Disease | myocardial infarction (biomarker_via_orthology) | 6.34e-04 | 160 | 126 | 5 | DOID:5844 (biomarker_via_orthology) | |
| Disease | lifestyle measurement, systolic blood pressure | 6.39e-04 | 9 | 126 | 2 | EFO_0006335, EFO_0010724 | |
| Disease | protein FAM163B measurement | 6.39e-04 | 9 | 126 | 2 | EFO_0802936 | |
| Disease | invasive ductal carcinoma (is_marker_for) | 6.69e-04 | 40 | 126 | 3 | DOID:3008 (is_marker_for) | |
| Disease | blood urea nitrogen measurement | 7.41e-04 | 452 | 126 | 8 | EFO_0004741 | |
| Disease | Adenocarcinoma of large intestine | 7.77e-04 | 96 | 126 | 4 | C1319315 | |
| Disease | endometrial hyperplasia (is_marker_for) | 7.96e-04 | 10 | 126 | 2 | DOID:0080365 (is_marker_for) | |
| Disease | adseverin measurement | 7.96e-04 | 10 | 126 | 2 | EFO_0801358 | |
| Disease | androstenedione measurement | 7.96e-04 | 10 | 126 | 2 | EFO_0007972 | |
| Disease | cell growth regulator with EF hand domain protein 1 measurement | 9.70e-04 | 11 | 126 | 2 | EFO_0801461 | |
| Disease | 3-hydroxyanthranilate 3,4-dioxygenase measurement | 9.70e-04 | 11 | 126 | 2 | EFO_0021862 | |
| Disease | non-alcoholic fatty liver disease | 1.13e-03 | 182 | 126 | 5 | EFO_0003095 | |
| Disease | hepatocellular carcinoma (implicated_via_orthology) | 1.21e-03 | 49 | 126 | 3 | DOID:684 (implicated_via_orthology) | |
| Disease | Colorectal Neoplasms | 1.25e-03 | 277 | 126 | 6 | C0009404 | |
| Disease | glycochenodeoxycholate glucuronide (1) measurement | 1.37e-03 | 13 | 126 | 2 | EFO_0800474 | |
| Disease | X-24588 measurement | 1.37e-03 | 13 | 126 | 2 | EFO_0800898 | |
| Disease | Beta blocking agent use measurement | 1.47e-03 | 114 | 126 | 4 | EFO_0009929 | |
| Disease | biliary atresia (is_marker_for) | 1.59e-03 | 14 | 126 | 2 | DOID:13608 (is_marker_for) | |
| Disease | Fanconi anemia | 1.59e-03 | 14 | 126 | 2 | cv:C0015625 | |
| Disease | diabetic retinopathy (is_marker_for) | 1.61e-03 | 54 | 126 | 3 | DOID:8947 (is_marker_for) | |
| Disease | prostate cancer (is_implicated_in) | 1.62e-03 | 117 | 126 | 4 | DOID:10283 (is_implicated_in) | |
| Disease | ecosanoids measurement | 1.70e-03 | 55 | 126 | 3 | EFO_0020044 | |
| Disease | hepatic encephalopathy (biomarker_via_orthology) | 1.83e-03 | 15 | 126 | 2 | DOID:13413 (biomarker_via_orthology) | |
| Disease | diabetic retinopathy (implicated_via_orthology) | 2.09e-03 | 16 | 126 | 2 | DOID:8947 (implicated_via_orthology) | |
| Disease | melanoma | 2.12e-03 | 126 | 126 | 4 | EFO_0000756 | |
| Disease | autoimmune thyroid disease | 2.12e-03 | 126 | 126 | 4 | EFO_0006812 | |
| Disease | hypertension (implicated_via_orthology) | 2.25e-03 | 128 | 126 | 4 | DOID:10763 (implicated_via_orthology) | |
| Disease | renal cell carcinoma (is_marker_for) | 2.25e-03 | 128 | 126 | 4 | DOID:4450 (is_marker_for) | |
| Disease | Calcium channel blocker use measurement | 2.25e-03 | 213 | 126 | 5 | EFO_0009930 | |
| Disease | Benign neoplasm of stomach | 2.36e-03 | 17 | 126 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 2.36e-03 | 17 | 126 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 2.36e-03 | 17 | 126 | 2 | C0154060 | |
| Disease | X-21441 measurement | 2.36e-03 | 17 | 126 | 2 | EFO_0800814 | |
| Disease | perinatal necrotizing enterocolitis (biomarker_via_orthology) | 2.36e-03 | 17 | 126 | 2 | DOID:8677 (biomarker_via_orthology) | |
| Disease | Bone marrow hypocellularity | 2.65e-03 | 18 | 126 | 2 | C1855710 | |
| Disease | non-alcoholic fatty liver disease (biomarker_via_orthology) | 2.74e-03 | 65 | 126 | 3 | DOID:0080208 (biomarker_via_orthology) | |
| Disease | polycystic kidney disease (biomarker_via_orthology) | 2.95e-03 | 19 | 126 | 2 | DOID:0080322 (biomarker_via_orthology) | |
| Disease | Severe Combined Immunodeficiency | 3.27e-03 | 20 | 126 | 2 | C0085110 | |
| Disease | gastric ulcer | 3.60e-03 | 21 | 126 | 2 | EFO_0009454 | |
| Disease | Stomach Carcinoma | 3.60e-03 | 21 | 126 | 2 | C0699791 | |
| Disease | Liver diseases | 3.66e-03 | 72 | 126 | 3 | C0023895 | |
| Disease | Liver Dysfunction | 3.66e-03 | 72 | 126 | 3 | C0086565 | |
| Disease | perceived unattractiveness to mosquitos measurement | 3.66e-03 | 72 | 126 | 3 | EFO_0008380 | |
| Disease | cholangiocarcinoma (is_implicated_in) | 3.95e-03 | 22 | 126 | 2 | DOID:4947 (is_implicated_in) | |
| Disease | seminoma (is_marker_for) | 3.95e-03 | 22 | 126 | 2 | DOID:4440 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| REAAQAIFPSMARAL | 391 | Q8TAA9 | |
| TLEERQQFMKAFRQP | 396 | Q96QE3 | |
| FSRMARDPQRFVVIQ | 976 | P04626 | |
| FDNANEPVLRFDQML | 271 | Q8IWZ6 | |
| QAPDLRNFRAVFMAV | 501 | Q7Z695 | |
| NTPAFFAERLNKAMR | 431 | P50995 | |
| DLMVEASPRRIFANA | 161 | P63151 | |
| AELFNEMLQRDFGVR | 771 | Q8IX12 | |
| AMLFALDRINNDPDL | 81 | Q14833 | |
| VLQMAFDELRRQRAF | 591 | Q9UKA4 | |
| DAAMRPSFLQLREQL | 426 | P41240 | |
| DFRFKHMQIRVNAEP | 221 | O14678 | |
| ILRQFPPDFRDQEAM | 31 | Q8IV53 | |
| DFMEQRRFSDIIFHP | 401 | Q3KR37 | |
| AMALFQIEQGIERRF | 1081 | Q9NRL2 | |
| IFSQERDPRFAEMFA | 486 | Q9HBZ2 | |
| FRFEMQRDLVSFPLS | 6 | O43502 | |
| MRAKLFRFASENDLP | 51 | P43487 | |
| RLEEFQLMRGEPFAS | 201 | Q96IZ5 | |
| PFFRAIMRDINKLEE | 836 | P23458 | |
| DAQRFMDLAPFLNLL | 416 | O15438 | |
| FMFLRQELPVRLANI | 76 | Q15118 | |
| ARPAFLKFLEQSMRE | 1181 | Q96PE2 | |
| MIAARDLQEFVPFGR | 11 | Q9H1A4 | |
| AREVAPRLAFASMFN | 106 | A6NGU5 | |
| EDDEIMQGFIRAFRP | 146 | P09466 | |
| LKDMAAFNERPIIFA | 391 | P48163 | |
| ELIRVPAFLDLFMQS | 326 | Q8IXH7 | |
| RDTIFQKERFNIDMP | 216 | Q05655 | |
| ELFMTDFPARLFLEN | 1221 | Q38SD2 | |
| VAMDEPFLQFRRNVF | 116 | Q9BZ67 | |
| IPMDDDFQLRSFDQL | 566 | Q16665 | |
| AFLRQPNIFEMLQER | 1121 | Q76N89 | |
| FLLDGFPRTVRQAEM | 96 | P54819 | |
| DQLMFLERAFIDPLG | 666 | Q04609 | |
| VAMDEPFLQFRRNVF | 116 | Q9BZ68 | |
| RENGSNLAFMFRLPF | 931 | Q5JUK3 | |
| EMANLRFVNFRDNPL | 266 | Q96DD0 | |
| NPFKRNQRMELLIAF | 706 | P26006 | |
| VPAAQNPEDLRMFAR | 501 | Q12980 | |
| QEPEFQRMSALRLAA | 396 | O95948 | |
| NEQFAIRRFQSMPVR | 141 | P30305 | |
| LPFQRLMREIAQDFK | 66 | Q16695 | |
| LNNILRAPMRFFDTT | 1061 | Q92887 | |
| FIEAPDFETLRAMNR | 491 | Q14168 | |
| RMNPAAFDFLLQRVE | 561 | Q07864 | |
| QILLMFKTRPEDFRD | 61 | P06213 | |
| PQFLADMENNVLFRD | 416 | Q96PQ7 | |
| LPFILEMFQQVDFNR | 476 | Q9Y3T9 | |
| NRMEIFRLNTIPLFV | 576 | P14923 | |
| RAMFLQPDLDSLVDF | 411 | Q9BQG0 | |
| NAFMKAVELARLAFP | 836 | Q9UG01 | |
| RIMINFNPHFDLEDR | 66 | O14786 | |
| PSFFMADELRQELIN | 441 | Q58A45 | |
| PIFRDFLNRCLEMDV | 471 | Q13177 | |
| GRNFIFFIDDLNMPA | 2286 | Q9P2D7 | |
| ILRDPELSFMAAQRN | 1986 | Q3L8U1 | |
| ERLEAFQQRMLSEFP | 1381 | Q8IZD9 | |
| IMDQQRLEPEFFRVG | 1306 | Q8N1I0 | |
| ADALLDLIRNMFPAN | 136 | O00341 | |
| DAFRNRLRMFPSLIN | 2571 | Q8TD57 | |
| INAFLDNMFGPRDSR | 11 | Q9NXB9 | |
| DLLQAMPRTEFARLN | 136 | Q8NDZ4 | |
| LMFRLFSEARQPLSE | 871 | O15360 | |
| FMLLTQARLFDEPQL | 181 | Q9H0C5 | |
| HFNEALFRPFERIMQ | 1251 | Q5TH69 | |
| LFRPFERIMQLELCD | 1256 | Q5TH69 | |
| RLVFNRPFLMFIVDN | 381 | P05154 | |
| LQKRQRPEVFSDNMF | 406 | Q9NZP8 | |
| RFLPMVDAVARDFSQ | 156 | P15538 | |
| IFERVRQSADFMPLK | 296 | Q8NI60 | |
| VRFFNRNFPEAMLKE | 2296 | Q9BZC7 | |
| RFMRLTFVPESLENL | 51 | O60266 | |
| EENFEAPAFLNMRKR | 376 | Q69YH5 | |
| FPFFGETLQMVLQRR | 51 | O43174 | |
| RFLPMVDAVARDFSQ | 156 | P19099 | |
| LFIDQGNRPLFEDMT | 56 | Q14116 | |
| NAFMLLTQARLFDEP | 221 | Q9BX70 | |
| PLQDFTLMRFLDRFV | 746 | Q03701 | |
| NLPFELQRNFQLMRD | 16 | Q9UNL4 | |
| AREVAPRLAFASMFN | 106 | P36268 | |
| MLEEIRSRQPFFTQR | 426 | Q16363 | |
| RVQARPFLFQQAMQA | 461 | Q3SY00 | |
| MPRNNQLLHFAFRED | 91 | Q9GZN7 | |
| FQERLRHMIPRQTDF | 136 | Q9C093 | |
| MVRDVFRLAKENAPA | 246 | P43686 | |
| NREPVGRIMFQLFSD | 16 | P30414 | |
| HFRPELEERMQRFAQ | 441 | P49821 | |
| EPAHINDFMFEQQRR | 116 | O60508 | |
| VLEGRFRIPFFMSQD | 236 | A0A0B4J2F2 | |
| VLEGRFRIPFFMSQD | 236 | P57059 | |
| DAALAVLEDRFQPNM | 171 | P40306 | |
| EPLLTFRLNRAFMEA | 431 | Q9H0H5 | |
| FNMFVRLFVDENLDR | 411 | O94818 | |
| NREINNPMFRFLFEN | 451 | O15042 | |
| LEDFQNMILRAPDFL | 166 | Q96Q77 | |
| RPRLALNVMADNFVF | 171 | Q96KA5 | |
| SFMRFQPRQREEILE | 361 | Q86X52 | |
| MEDDANFFLSLIRAP | 351 | Q9H2A9 | |
| EEEFLLTIRPFANRM | 11 | Q96LP6 | |
| PFDQQFNILMRFIVD | 971 | Q7Z460 | |
| ESFPNDLQFNILMRF | 766 | O75122 | |
| ERFKPEMFAELLQAA | 201 | Q70EK8 | |
| AQFLLQFAFRDDMPL | 726 | Q15735 | |
| QFAFRDDMPLVRLEV | 731 | Q15735 | |
| LFQDLQDLFDPSRNM | 836 | Q9Y4G8 | |
| NLRMFQRAQDDLIPA | 91 | Q9NUL5 | |
| RVRVFDREIAQMFLN | 261 | O95985 | |
| GPAFRNLTELDMRFN | 631 | O15455 | |
| RFFTEILRMDPRNAV | 641 | Q8WVT3 | |
| FAEMKLRPSNFRNLE | 2181 | P24821 | |
| NEFLAFEGPILLDMR | 181 | O60281 | |
| MEFLADLLFFPQRDS | 991 | Q6P2S7 | |
| AQFFIHPLMIRDAID | 291 | O43847 | |
| QLARPSDANRKEMLF | 316 | O43847 | |
| MADSQRFRQFILLTP | 1036 | Q96SB8 | |
| FNIMEIQPFRRAAAI | 451 | O75326 | |
| EEVGRLFRTNMFNIP | 261 | Q96LQ0 | |
| IFAINGDLVFMRPFN | 636 | Q70Z35 | |
| AAFRSMLRQAVPALE | 631 | Q6NWY9 | |
| RPDMFRAQQLQIFNL | 151 | O43566 | |
| PMAFSLERQFRSQAF | 291 | Q9Y5Z9 | |
| LRDVFNMDFPDNSFL | 81 | Q00722 | |
| FQMFPADRKRVEAAL | 171 | Q00722 | |
| PSEMINNAENLFRAF | 186 | P78527 | |
| QRLLMFSFVNDRFMP | 216 | A2A288 | |
| MNVENPFIRRQIFRS | 706 | Q9BY31 | |
| RFQNMLEFQTPELLR | 756 | Q9H6S0 | |
| FQEAFRNLVPVTRVM | 81 | Q13342 | |
| MQAPRAALVFALVIA | 1 | Q6P9G4 | |
| LQMFQALKRPDDTAF | 741 | O94901 | |
| EAVELFIRLRPAMQF | 301 | Q6WRX3 | |
| FAEFVLHLNRLNPEM | 3681 | Q9Y4A5 | |
| AREVAPRLAFATMFN | 106 | P19440 | |
| IEMNRQQRFFRIPFI | 1171 | Q9UM54 |